Analysis of the efficacy of decitabine combined with bortezomib and dexamethasone in the treatment of relapsed or refractory multiple myeloma

LIU Qing; ZHAO Min; LIU Li-na; LIU Yu-zhang; FANG Bai-jun

doi:10.19538/j.nk2022050115

Home>Articles>Analysis of the efficacy of decitabine combined with bortezomib and dexamethasone in the treatment of relapsed or refractory multiple myeloma

DOI: 10.19538/j.nk2022050115

Analysis of the efficacy of decitabine combined with bortezomib and dexamethasone in the treatment of relapsed or refractory multiple myeloma

LIU Qing

ZHAO Min

LIU Li-na

LIU Yu-zhang

FANG Bai-jun

Machine-generated Keywords：

Publication Date：2022-05-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 414-417 )

Chinese Journal of Practical Internal Medicine

ISTICPKU

ISSN：1005-2194

Year, Vol.(Issue)：2022,42(5)